FDA Inspection
Hangzhou Zhongmei Huadong Pharmaceutical Co., LtdHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd – FDA Inspection, Aug 18, 2023
Record Details
This FDA Inspection record concerns Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, with an inspection on August 18, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 18, 2023
- Product Type
- Drugs
View Company Profile
ID · 56605c3c-e0e9-4939-8447-0885ce9f48bc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1217084
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | Office of Inspections and Investigations | |
| August 23, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2017 | Not classified | Office of Inspections and Investigations | |
| July 28, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 2, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- FDA Inspection 1341100 - 2026-09-18
- FDA Inspection 1064409 - 2018-08-23
- FDA Inspection 1006423 - 2017-02-28
- FDA Inspection 985170 - 2016-07-28
- FDA Inspection 880928 - 2014-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.